Jocelyn Weiss

1.2k total citations
17 papers, 953 citations indexed

About

Jocelyn Weiss is a scholar working on Molecular Biology, Endocrinology, Diabetes and Metabolism and Cancer Research. According to data from OpenAlex, Jocelyn Weiss has authored 17 papers receiving a total of 953 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 5 papers in Endocrinology, Diabetes and Metabolism and 5 papers in Cancer Research. Recurrent topics in Jocelyn Weiss's work include RNA modifications and cancer (4 papers), Growth Hormone and Insulin-like Growth Factors (4 papers) and Cancer Research and Treatments (3 papers). Jocelyn Weiss is often cited by papers focused on RNA modifications and cancer (4 papers), Growth Hormone and Insulin-like Growth Factors (4 papers) and Cancer Research and Treatments (3 papers). Jocelyn Weiss collaborates with scholars based in Australia, Switzerland and Netherlands. Jocelyn Weiss's co-authors include Carolyn D. Scott, Himanshu Brahmbhatt, Jennifer A. MacDiarmid, Nancy B. Amaro-Mugridge, David B. O’Gorman, Sue M. Firth, Glen Reid, Nico van Zandwijk, Marissa Williams and Michaela B. Kirschner and has published in prestigious journals such as PLoS ONE, Cancer Cell and Cancer Research.

In The Last Decade

Jocelyn Weiss

17 papers receiving 933 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jocelyn Weiss Australia 15 596 385 137 122 102 17 953
Chen Sun China 16 582 1.0× 282 0.7× 629 4.6× 56 0.5× 53 0.5× 34 1.1k
Sandra Wiehle United States 11 559 0.9× 150 0.4× 234 1.7× 120 1.0× 210 2.1× 11 957
Ilya Sedliarou Japan 8 289 0.5× 85 0.2× 33 0.2× 152 1.2× 116 1.1× 10 562
Seema V. Garde India 15 389 0.7× 117 0.3× 373 2.7× 176 1.4× 42 0.4× 45 909
Dianzhong Luo China 16 458 0.8× 250 0.6× 90 0.7× 12 0.1× 95 0.9× 27 946
Gang Xue China 14 219 0.4× 104 0.3× 74 0.5× 47 0.4× 75 0.7× 39 710
Chun Chou United States 17 485 0.8× 211 0.5× 74 0.5× 17 0.1× 63 0.6× 22 1.4k
Cristina Belgiovine Italy 17 447 0.8× 149 0.4× 131 1.0× 14 0.1× 87 0.9× 34 1.0k
Guoqing Ru China 17 463 0.8× 262 0.7× 232 1.7× 10 0.1× 79 0.8× 70 941
Pezhman Fard‐Esfahani Iran 16 405 0.7× 277 0.7× 40 0.3× 127 1.0× 16 0.2× 44 670

Countries citing papers authored by Jocelyn Weiss

Since Specialization
Citations

This map shows the geographic impact of Jocelyn Weiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jocelyn Weiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jocelyn Weiss more than expected).

Fields of papers citing papers by Jocelyn Weiss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jocelyn Weiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jocelyn Weiss. The network helps show where Jocelyn Weiss may publish in the future.

Co-authorship network of co-authors of Jocelyn Weiss

This figure shows the co-authorship network connecting the top 25 collaborators of Jocelyn Weiss. A scholar is included among the top collaborators of Jocelyn Weiss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jocelyn Weiss. Jocelyn Weiss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Reid, Glen, Marissa Williams, Yuen Yee Cheng, et al.. (2025). Therapeutic potential of synthetic microRNA mimics based on the miR-15/107 consensus sequence. Cancer Gene Therapy. 32(4). 486–496. 2 indexed citations
2.
Weiss, Jocelyn, Anthony J. Gill, Roderick Clifton‐Bligh, et al.. (2019). RET Kinase-Regulated MicroRNA-153-3p Improves Therapeutic Efficacy in Medullary Thyroid Carcinoma. Thyroid. 29(6). 830–844. 24 indexed citations
3.
Weiss, Jocelyn, Anthony J. Gill, Roderick Clifton‐Bligh, et al.. (2018). Abstract 501: A RET-related microRNA, miR-153-3p, acts as a tumor suppressor in medullary thyroid carcinoma (MTC) via S6K signaling. Cancer Research. 78(13_Supplement). 501–501. 3 indexed citations
4.
Alfaleh, Mohamed A., Christopher B. Howard, Ilya Sedliarou, et al.. (2017). Targeting mesothelin receptors with drug-loaded bacterial nanocells suppresses human mesothelioma tumour growth in mouse xenograft models. PLoS ONE. 12(10). e0186137–e0186137. 14 indexed citations
5.
Zhao, Jing, Jocelyn Weiss, Nancy B. Amaro-Mugridge, et al.. (2017). Translational applications of microRNAs in cancer, and therapeutic implications. Non-coding RNA Research. 2(3-4). 143–150. 35 indexed citations
6.
Williams, Marissa, Michaela B. Kirschner, Yuen Yee Cheng, et al.. (2015). miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma. Oncotarget. 6(27). 23480–23495. 64 indexed citations
7.
Glover, Anthony, Jing Zhao, Anthony J. Gill, et al.. (2015). microRNA-7 as a tumor suppressor and novel therapeutic for adrenocortical carcinoma. Oncotarget. 6(34). 36675–36688. 74 indexed citations
8.
Reid, Glen, Marissa Williams, Michaela B. Kirschner, et al.. (2015). Abstract 3976: Targeted delivery of a synthetic microRNA-based mimic as an approach to cancer therapy. Cancer Research. 75(15_Supplement). 3976–3976. 14 indexed citations
9.
Baraz, Rana, Adam Cisterne, John Hewson, et al.. (2014). mTOR Inhibition by Everolimus in Childhood Acute Lymphoblastic Leukemia Induces Caspase-Independent Cell Death. PLoS ONE. 9(7). e102494–e102494. 28 indexed citations
10.
Reid, Glen, Michaela B. Kirschner, Yuen Yee Cheng, et al.. (2013). Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma. Annals of Oncology. 24(12). 3128–3135. 202 indexed citations
11.
Weiss, Jocelyn, et al.. (2012). RAD001 (everolimus) induces dose-dependent changes to cell cycle regulation and modifies the cell cycle response to vincristine. Oncogene. 32(40). 4789–4797. 15 indexed citations
12.
13.
MacDiarmid, Jennifer A., Nancy B. Amaro-Mugridge, Jocelyn Weiss, et al.. (2007). Bacterially Derived 400 nm Particles for Encapsulation and Cancer Cell Targeting of Chemotherapeutics. Cancer Cell. 11(5). 431–445. 236 indexed citations
14.
Lee, Jason S., Jocelyn Weiss, Janet L. Martin, & Carolyn D. Scott. (2003). Increased expression of the mannose 6‐phosphate/insulin‐like growth factor‐II receptor in breast cancer cells alters tumorigenic properties in vitro and in vivo. International Journal of Cancer. 107(4). 564–570. 35 indexed citations
15.
O’Gorman, David B., Jocelyn Weiss, Anusha Hettiaratchi, Sue M. Firth, & Carolyn D. Scott. (2002). Insulin-Like Growth Factor-II/Mannose 6-Phosphate Receptor Overexpression Reduces Growth of Choriocarcinoma Cellsin Vitroandin Vivo. Endocrinology. 143(11). 4287–4294. 73 indexed citations
16.
Scott, Carolyn D. & Jocelyn Weiss. (2000). Soluble insulin-like growth factor II/mannose 6-phosphate receptor inhibits DNA synthesis in insulin-like growth factor II sensitive cells. Journal of Cellular Physiology. 182(1). 62–68. 28 indexed citations
17.
O’Gorman, David B., Michael Costello, Jocelyn Weiss, Sue M. Firth, & Carolyn D. Scott. (1999). Decreased insulin-like growth factor-II/mannose 6-phosphate receptor expression enhances tumorigenicity in JEG-3 cells.. PubMed. 59(22). 5692–4. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chen Sun Breakdown of academic impact, for papers by Sandra Wiehle Breakdown of academic impact, for papers by Ilya Sedliarou Breakdown of academic impact, for papers by Seema V. Garde Breakdown of academic impact, for papers by Dianzhong Luo Breakdown of academic impact, for papers by Gang Xue Breakdown of academic impact, for papers by Chun Chou Breakdown of academic impact, for papers by Cristina Belgiovine Breakdown of academic impact, for papers by Guoqing Ru Breakdown of academic impact, for papers by Pezhman Fard‐Esfahani
Rankless by CCL
2026